Printer Friendly

Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies.

NEW YORK, Nov. 16, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Top Ten World's Leading Pharmaceutical Companies

http://www.reportlinker.com/p0329551/Top-Ten-World's-Leading-Pharmaceutical-Companies.html

A thought-provoking report on performance, capabilities, goals and strategies of the major competitors in the worldwide pharmaceutical market. The report is designed to provide the pharmaceutical industry executives with strategically significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report's major objectives include:

* To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world's leading pharmaceutical companies.

* To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis leading competitors.

* To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.

* To complement organizations' internal competitor information gathering efforts by providing strategic analysis, data interpretation and insight.

* To identify the least competitive market niches with significant growth potential.

Contains 1,200 pages and 100 tables

SECTION I: EXECUTIVE SUMMARY

-- A 5-10 page synopsis of key sections.

SECTION II: BUSINESS ORGANIZATION

-- History of the company's pharmaceutical business evolution,

which is important to understanding the corporate culture,

management mentality, and strategies.

-- Most recent M&A activity and significant organizational changes.

-- Current organizational structure.

SECTION III: SENIOR MANAGEMENT

-- Names, titles, and background of senior managers.

SECTION IV: FACILITIES AND EMPLOYEES

-- Major administrative, manufacturing, and R&D facilities

in the U.S. and abroad.

-- Manufacturing practices.

-- New plants under construction.

-- U.S. and international work force size and distribution.

SECTION V: TECHNOLOGICAL KNOW-HOW

-- Internally developed and acquired technologies,

processes, and related capabilities.

-- Know-how in biotechnology and other pertinent fields.

-- Proprietary technologies and patent litigations.

SECTION VI: PRODUCT PORTFOLIO ANALYSIS

-- Extensive review of major ethical, OTC, and generic drugs.

-- Most recent new drug introductions and indications.

SECTION VII: MARKETING TACTICS

-- Sales force in the U.S., Europe, and other regions.

-- Distribution strategies.

-- Major promotional tactics.

SECTION VIII: FINANCIAL ANALYSIS

-- The U.S. and international sales and operating profit estimates by

division, geographic region, therapeutic category, and individual drug.

-- The five-year sales and operating profit performance.

-- AstraZeneca

-- Eli Lilly

-- GlaxoSmithKline

-- Johnson & Johnson

-- Merck

-- Novartis

-- Pfizer

-- Roche

-- Sanofi-Aventis

-- Wyeth

SECTION IX: R&D EXPENDITURES AND

MAJOR PROGRAMS

-- The R&D budget.

-- Research facilities and staff.

-- New technologies, drugs, and indications in development,

including their phase and anticipated introduction dates.

-- Worldwide sales force size.

SECTION X: COLLABORATIVE ARRANGEMENTS

-- Major joint venture, distribution, OEM, and licensing partners, both

industrial and academic.

-- Terms of collaborative agreements and specific products involved.

SECTION XI: STRATEGIC DIRECTION

-- Major strengths and weaknesses.

-- Business, new product development, and marketing objectives

and strategies.

-- Anticipated acquisitions, joint ventures, and divestitures.

LIST OF TABLES

Table MO-1: World Pharmaceutical Market

by Major Product Segment

Table MO-2: World Ethical Pharmaceutical Market

by Geographic Region/Country

Table MO-3: World Ethical Pharmaceutical Market

by Major Drug Category

Table AZ-1: AstraZeneca Sales and Operating Profit Growth

Table AZ-2: AstraZeneca Sales by Therapeutic Category/Business

Table AZ-3: AstraZeneca Sales Growth by Therapeutic

Category/Business

Table AZ-4: AstraZeneca Sales by Major Drug/Business

Table AZ-5: AstraZeneca Sales Growth by Major Drug/Business

Table AZ-6: AstraZeneca Sales by Major Drug/Business and

Geographic Region

Table AZ-7: AstraZeneca Sales by Geographic Region and

Country

Table AZ-8: AstraZeneca Sales Growth by Geographic Region and

Country

Table BM-1: Bristol-Myers Squibb Sales and Operating Profit

Growth

Table BM-2: Bristol-Myers Squibb Sales by Major Division

Table BM-3: Bristol-Myers Squibb Sales by Major Division and

Geographic Region

Table BM-4: Bristol-Myers Squibb Sales Growth by Major Division

Table BM-5: Bristol-Myers Squibb Sales by Therapeutic Category

Table BM-6: Bristol-Myers Squibb Sales by Therapeutic Category

and Geographic Region

Table BM-7: Bristol-Myers Squibb Sales Growth by Therapeutic

Category

Table BM-8: Bristol-Myers Squibb Sales by Major Drug

Table BM-9: Bristol-Myers Squibb Sales Growth by Major Drug

Table BM-10: Bristol-Myers Squibb Sales by Product Line

Table BM-11: Bristol-Myers Squibb Sales Growth by Product Line

Table BM-12: Bristol-Myers Squibb Sales by Geographic Region

Table BM-13: Bristol-Myers Squibb Sales Growth by Geographic

Region

Table BM-14: Bristol-Myers Squibb Other Health Care Sales by

Product

Table GL-1: GlaxoSmithKline Sales by Business Segment

Table GL-2: GlaxoSmithKline Sales Growth by Business Segment

Table GL-3: GlaxoSmithKline Operating Profit And Margins by

Business Segment

Table GL-4: GlaxoSmithKline Operating Profit by Business

Segment

Table GL-5: GlaxoSmithKline Sales and Operating Profit Growth

Table GL-6: GlaxoSmithKline Sales by Major Drug

Table GL-7: GlaxoSmithKline Sales by Drug and Geographic Region

Table GL-8: GlaxoSmithKline Sales by Therapeutic Category

Table GL-9: GlaxoSmithKline Sales Growth by Therapeutic

Category

Table GL-10: GlaxoSmithKline Sales by Geographic Region and Country

Table GL-11: GlaxoSmithKline Sales Growth by Geographic Region

Table GL-12: GlaxoSmithKline Consumer Healthcare Sales by

Product Line

Table GL-13: GlaxoSmithKline Consumer Healthcare Sales Growth

by Product Line

Table JJ-1: Johnson & Johnson Sales by Geographic Region and

Country

Table JJ-2: Johnson & Johnson Sales Growth by Geographic

Region

Table JJ-3: Johnson & Johnson Sales by Business Segment and

Geographic Region

Table JJ-4: Johnson & Johnson Sales and Operating Profit Growth

Table JJ-5: Johnson & Johnson Sales by Major Drug

Table JJ-6: Johnson & Johnson Pharmaceutical Sales Growth by

Major Drug

Table JJ-7: Johnson & Johnson Consumer Segment Sales by

Product Line

Table JJ-8: Johnson & Johnson Consumer Segment Sales Growth

by Product Line

Table ME-1: Merck Sales and Operating Profit Growth

Table ME-2: Merck Sales by Geographic Region

Table ME-3: Merck Sales Growth by Geographic Region

Table ME-4: Merck Sales by Therapeutic Category

Table ME-5: Merck Sales Growth by Therapeutic Category

Table ME-6: Merck Sales By Major Drug

Table ME-7: Merck Sales Growth by Major Drug

Table ME-8: Merck Sales By Major Drug and Geographic Region

Table NO-1: Novartis Sales and Operating Profit Growth

Table NO-2: Novartis Sales by Business Segment

Table NO-3: Novartis Sales Growth by Business Segment

Table NO-4: Novartis Operating Profit by Business Segment

Table NO-5: Novartis Operating Profit Growth by Business

Segment

Table NO-6: Novartis Sales by Country

Table NO-7: Novartis Sales Growth by Country

Table NO-8: Novartis Sales by Therapeutic Category

Table NO-9: Novartis Sales Growth by Therapeutic Category

Table NO-10: Novartis Sales of Top 20 Drugs

Table NO-11: Novartis Sales Growth by Major Drug

Table PF-1: Pfizer Sales by Division

Table PF-2: Pfizer Sales and Operating Profit Growth

Table PF-3: Pfizer Sales by Therapeutic Category

Table PF-4: Pfizer Sales by Major Product

Table PF-5: Pfizer Sales Growth by Major Product

Table PF-6: Pfizer Sales by Geographic Region

Table PF-7: Pfizer Sales Growth by Geographic Region

Table RO-1: Roche Sales and Operating Profit Growth

Table RO-2: Roche Sales by Major Division

Table RO-3: Roche Sales Growth by Business Segment

Table RO-4: Roche Sales by Geographic Region

Table RO-5: Roche Sales Growth by Geographic Region

Table RO-6: Roche Sales and Operating Profit Growth

Table RO-7: Roche Sales by Division

Table RO-8: Roche Operating Profit by Division

Table RO-9: Roche Operating Profit Growth by Division

Table RO-10: Roche Sales by Therapeutic Category

Table RO-11: Roche Sales of Top 20 Products

Table SA-1: Sanofi-Aventis Sales and Operating Profit Growth

Table SA-2: Sanofi-Aventis Sales by Business Segment

Table SA-3: Sanofi-Aventis Sales Growth by Business Segment

Table SA-4: Sanofi-Aventis Sales of Top 15 Drugs

Table SA-5: Sanofi-Aventis Sales Growth of Top 15 Drugs

Table SA-6: Sanofi-Aventis Sales of 15 Major Drugs and

Geographic Region

Table SA-7: Sanofi-Aventis Sales by Geographic Region

Table SA-8: Sanofi-Aventis Vaccine Sales by Major Product

Table WY-1: Wyeth Sales by Business Segment

Table WY-2: Wyeth Sales Growth by Business Segment

Table WY-3: Wyeth Sales and Operating Profit Growth

Table WY-4: Wyeth Sales by Therapeutic Category

Table WY-5: Wyeth Sales by Major Drug

Table WY-6: Wyeth Consumer Healthcare Sales by Product

Table WY-7: Wyeth Consumer Healthcare Sales Growth by

Product

Table CA-1: The Top 10 World's Leading Pharmaceutical

Companies Sales, Rank, and Market Share

Table CA-2: The Top 10 World's Leading Pharmaceutical

Companies Operating Profit, Margins, and Rank

Table CA-3: The Top 10 World's Leading Pharmaceutical

Companies R&D Expenditures, Percent of Sales,

and Rank

To order this report:

Pharmaceutical Industry: Top Ten World's Leading Pharmaceutical Companies

Pharmaceutical Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!


Nicolas Bombourg


Reportlinker


Email: nbo@reportlinker.com


US: (805)652-2626


Intl: +1 805-652-2626


SOURCE Reportlinker
COPYRIGHT 2010 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:1U2NY
Date:Nov 16, 2010
Words:2006
Previous Article:Reportlinker Adds Global Imaging Agents Industry.
Next Article:AJC Congratulates Archbishop Dolan on Election as USCCB President.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters